Nyrada Quarterly Activities Report & Appendix 4C Jul 27, 2021 ASX News Nyrada Inc (ASX:NYR) Send Share Share
Incannex Interim review of proprietary PsiGAD clinical trial data indicates no safety concerns and projects a statistically significant benefit for the psilocybin arm versus the placebo arm in those participants who have completed the treatment Mar 15, 2023 | ASX News, Incannex Healthcare (ASX:IHL)
Nyrada Inc (ASX:NYR) Cholesterol-Lowering Program Pathway To Phase I Dec 22, 2021 | ASX News, Nyrada Inc (ASX:NYR)